Clinical trials

Valutazione dell'efficacia delle cellule stromali mesenchimali autologhe derivate da tessuto adiposo nel trattamento di pazienti con osteoartrosi del ginocchio (ARTE) - Eudract number: 2020-005336-29

Studio prospettico randomizzato multicentrico di fase l/lla sull'impiego di cellule stromali mesenchimali allogeniche nel trattamento di pazienti affetti da polmonite da SARS-COV-2 (RESCAT). Eudract number 2020-001577-70

Intervertebral disc regeneration mediated by autologous mesenchymal stem/stromal cells intradiscal injection: a phase IIB randomized clinical trial (DREAM) - Eudract number 2019-002749-40

Autologous mesenchymal stem/stromal cells for the treatment of workers affected by chronic low back pain due to multilevel intervertebral disc degeneration: a phase iib randomized clinical trial (ACTIVE) - Eudract number 2019-004476-19

A multi-centre, open-label, randomized, comparative clinical trial of two different doses of bone marrow autologous human mesenchymal stem cells plus biomaterial versus iliac crest autologous graft, for bone healing in non-union after long bone fractures (ORTHOUNION) - Eudract number 2015-000431-32

A phase 2 open-label study to evaluate the efficacy of allogeneic human cord blood-derived mesenchymal stromal cells in maintaining remission after immunosuppressive therapy withdrawal in pediatric patients with steroid-dependent nephrotic syndrome (RACE) - Eudract number 2018-00162-42

Rationale on safety in bone marrow mesenchymal stem cells use from third party donors, in patients with avascular necrosis of the femoral head developed following stem cell transplantation - Eudract number 2014-000516-34

Evaluation of safety and feasibility of bone marrow derived autologous mesenchymal stem cells to enhance bone healing in patients with avascular necrosis of the femoral head – Eudract number 2012-002010-39

Jaw bone reconstruction using a combination of autologous bone mesenchymal stem cells and biomaterial prior to dental implant placement – Eudract number 2012-003139-50

Allogeneic cord blood mesenchymal stem cells for lung repair in neonatal pulmonary dysplasia – Eudract number 2012-001456-19

Evaluation of efficacy and safety of autologous bone marrow mesenchymal stem cells combined to biomaterials to enhance bone healing in patients with delayed consolidation after long bone fracture requiring graft apposition or alternative orthobiologics - Eudract number 2011-005441-13

Allogenic cord blood mesenchymal stem cells for kidney disease (KID’S) –Eudract number 2011-001387-21

Autologous bone marrow mesenchymal stem cells for Progressive Sopranuclear Palsy patients - Eudract number 2011-004051-39

CD133+ cells for end-stage liver disease – Eudract number 2009-01178310

CD133+ cells from BM and PB for myocardial repair (Eudract number not available, submitted before May 1st 2004)

CD34+ expanded progenitor cells from cord blood in blood disorders (Eudract number not available, submitted before May 1st 2004)